Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,531,784
+$638,713 QoQ
Shares Held
18,009
+0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,377
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DAVIS R M INC holds $148,422,330 across 9 Drug Manufacturers - General names. ABBV ranks #3 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
61,458 | $73,714,575 | |
| 2 | JNJ |
Johnson & Johnson
|
249,911 | $63,469,896 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
18,009 | $4,531,784 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,586 | $3,030,801 | |
| 5 | AMGN |
Amgen Inc
|
6,701 | $2,426,566 | |
| 6 | AZN |
Astrazeneca PLC
|
1,871 | $354,779 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,425 | $312,588 | |
| 8 | PFE |
Pfizer Inc
|
12,484 | $300,614 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,531,784 | 18,009 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,893,071 | 17,900 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,890,042 | 17,025 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,596,047 | 15,531 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,092,429 | 16,660 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,324,073 | 20,638 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $3,102,642 | 17,460 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,809,981 | 19,293 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,329,889 | 19,414 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,525,638 | 19,361 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,092,426 | 19,955 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,211,199 | 21,543 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,106,739 | 23,059 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,541,042 | 22,219 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $3,790,724 | 23,456 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,168,161 | 23,606 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $3,854,884 | 25,169 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,991,634 | 24,623 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $2,834,192 | 20,932 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,264,407 | 20,992 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,401,597 | 21,321 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,234,959 | 20,652 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $2,260,543 | 21,097 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $1,606,050 | 18,336 | Shares | Sole | 2020-12-01 | |
| 2020-06-30 | $1,704,306 | 17,359 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $1,331,115 | 17,471 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||